NCT06220188View on ClinicalTrials.gov

PSMA-RLT in Biochemically Recurrent PCa

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

January 31, 2027

Conditions
Prostate Cancer Recurrent
Interventions
DRUG

[177Lu]Lu-PSMA I&T

2 cycles (3 GBq in first cycle and 6 GBq in the second cycle) of \[177Lu\]Lu-PSMAI\&T radioligand therapy at 6-week intervals

Trial Locations (1)

1090

RECRUITING

Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER